LCMS
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike

An Automated Sampling System for Online Monitoring as a Process Analytical Technology (PAT) Tool

Applications | 2021 | Agilent TechnologiesInstrumentation
2D-LC
Industries
Pharma & Biopharma
Manufacturer
Agilent Technologies, EST Analytical

Summary

Significance of the Topic


The development of real-time, automated analytical methods for bioprocess monitoring is essential to ensure consistent product quality and streamline biotherapeutic manufacturing. Integrating automated sampling with advanced chromatographic techniques provides immediate feedback on critical quality attributes (CQAs), aligning with regulatory Quality by Design (QbD) and Process Analytical Technology (PAT) initiatives.

Objectives and Overview of the Study


  • Demonstrate an automated UHPLC-based PAT tool combining Agilent 1290 Infinity II 2D-LC with the Flownamics Seg-Flow sampling system.
  • Enable online measurement of multiple CQAs (titer, size variants, charge variants, amino acid concentration) from upstream bioreactor samples using a single setup.
  • Reduce analysis time and cost during biotherapeutics development while improving process control.

Methodology and Instrumentation


The study uses a two-dimensional LC approach where a protein A affinity column in the first dimension captures monoclonal antibodies (mAbs), and subsequent second-dimension separations analyze size variants by SEC, charge variants by WCX/SCX, and amino acid concentrations via in-loop OPA/FMOC derivatization.

Instrumentation


  • Agilent 1290 Infinity II 2D-LC system: high-speed pumps, multisampler with cooler, multicolumn thermostats, diode array detectors, fluorescence detector, valve drives with heart-cutting and flow-splitting capability.
  • Flownamics Seg-Flow automated sampling system with FISP probe for sterile, cell-free bioreactor sampling.
  • Software: Agilent ChemStation with 2D-LC module and Flownamics FlowWeb for scheduling and OPC-enabled feedback control.

Main Results and Discussion


  • High-resolution heart-cutting and 1:10 flow-splitting reduced second-dimension run time by tenfold, enabling a single injection for multiple CQAs.
  • Protein A first-dimension provided real-time titer data; diverted fraction was directed to SEC to quantify monomer and high-molecular-weight species.
  • WCX and SCX separations resolved acidic and basic charge variants across multiple fractions.
  • In-loop OPA/FMOC derivatization and FLD detection allowed automated online amino acid profiling throughout the bioreactor cycle.

Benefits and Practical Applications


  • Simultaneous online monitoring of titer, size/charge variants, and amino acids enhances process understanding and decision-making.
  • Significant reduction in analysis time and labor compared to traditional offline assays.
  • Real-time integration with distributed control systems (DCS/SCADA) enables proactive feedback control consistent with PAT and QbD principles.

Future Trends and Potential Applications


  • Extension to other chromatographic modalities: RP-HPLC, HIC, HILIC, affinity chromatography, reduced/nonreduced denaturing SEC.
  • Incorporation of multivariate data analysis (PCA, PLS) for predictive process control and deeper data interpretation.
  • Integration of inline spectroscopic sensors (Raman, NIR, FTIR) with 2D-LC outputs for comprehensive real-time analytics.
  • Advancement toward fully closed-loop control strategies using OPC-enabled SCADA and enhanced scheduling software.

Conclusion


The Agilent 1290 Infinity II 2D-LC system interfaced with Flownamics Seg-Flow provides a powerful, fully automated platform for online assessment of multiple bioprocess CQAs. By combining affinity capture, heart-cutting or split-flow with SEC, ion exchange, and amino acid derivatization, the approach delivers rapid, reliable data that drive efficient process development and robust quality control in biopharmaceutical production.

Reference


  1. FDA. Guidance for Industry. PAT – A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance. 2004.
  2. Moussa EM, et al. Immunogenicity of Therapeutic Protein Aggregates. J Pharm Sci. 2016;105(2):417–430.
  3. Polumuri SK, et al. Aggregates of IVIG or Avastin Modify Innate Immune Response Modulating Impurities. Sci Rep. 2018;8(1):11477.
  4. Yan Y, et al. Ultrasensitive Characterization of Charge Heterogeneity of Therapeutic mAbs Using SCX and Native MS. Anal Chem. 2018;90:13013–13020.
  5. Kaschak T, et al. Characterization of the Basic Charge Variants of a Human IgG. mAbs. 2011;3(6):577–583.
  6. Chemmalil L, et al. Online Monitoring and Control of Upstream Cell Culture Process Using 1D & 2D-LC with SegFlow Interface. Biotechnol Bioeng. 2020;doi:10.1002/bit.27531.
  7. Agilent Technologies. Automation of Sample Derivatization Using the Agilent 1260 Infinity II Prime LC System for Amino Acid Analysis. Application Note 5994-2189EN. 2020.
  8. Nicola M, et al. SCADA Systems Architecture Based on OPC and Web Servers for Industrial Process Control. Int J Control Sci Eng. 2018;8(1):13–21.
  9. Chemmalil L, et al. Online/At-Line Measurement, Analysis and Control of Product Titer and CQAs During Process Development. Biotechnol Bioeng. 2020;doi:10.1002/bit.27531.

Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.

Downloadable PDF for viewing
 

Similar PDF

Toggle
Multiple Critical Quality Attributes Assessment of mAbs for Process Control
Application Note Biopharma/Pharma Multiple Critical Quality Attributes Assessment of mAbs for Process Control Agilent InfinityLab Online LC Solution for automated heart-cutting 2D-LC experiments Author Edgar Naegele Agilent Technologies, Inc. Abstract This application note demonstrates the capability of the Agilent Online…
Key words
dimension, dimensiononline, onlinemab, mabagilent, agilentfirst, firstsecond, secondprotein, proteintiter, titercqas, cqasrituximab, rituximabsec, secinfinitylab, infinitylabmonitoring, monitoringiec, iecpurification
Automated Bioprocess Monitoring with Agilent 1290 Infinity III Bio Online LC Solutions
Application Note Biopharma/Pharma Automated Bioprocess Monitoring with Agilent 1290 Infinity III Bio Online LC Solutions Process analytics of L-alanine production using genetically modified Vibrio natriegens Authors Abstract Adem Cakar and Manfred Maier Agilent Technologies, Inc. This application note illustrates the…
Key words
flownamics, flownamicsbioreactor, bioreactorbioprocess, bioprocessalanine, alanineseg, segamino, aminosampling, samplingnatriegens, natriegensmonitoring, monitoringvibrio, vibriosanitizer, sanitizeragar, agarwere, wereproduction, productionderivatization
Agilent 1290 Infinity II 2D-LC solution Biopharmaceutical Polymer Analysis
Agilent 1290 Infinity II 2D-LC Solution Biopharmaceutical Polymer Analysis WCBP Jan 2017 Washington, DC 1 Overview • Resolving power and how to measure it • Why two-dimensional LC? • Setup of a 2D-LC System • Different modes of 2D-LC •…
Key words
dimension, dimensionheart, heartwcx, wcxcutting, cuttingcharged, chargedhilic, hilicwax, waxcharge, chargeinnovator, innovatorcuts, cutsmultiple, multipleanalysis, analysistiter, titerpeak, peakmonoclonal
Multi-Attribute Analysis of Monoclonal Antibodies Using the Agilent InfinityLab 2D-LC Solution and Q-TOF MS
Application Note Pharma & Biopharma Multi-Attribute Analysis of Monoclonal Antibodies Using the Agilent InfinityLab 2D-LC Solution and Q-TOF MS Authors Gerd Vanhoenacker, Isabel Vandenheede, Pat Sandra, and Koen Sandra Research Institute for Chromatography (RIC) Kortrijk, Belgium Sonja Krieger, Sonja Schneider,…
Key words
mab, mabclone, cloneprotein, proteinsec, secheart, heartcutting, cuttingmau, mautocilizumab, tocilizumabcounts, countsoriginator, originatoractemra, actemrasupernatants, supernatantsdimension, dimensionvariants, variantsmain
Other projects
GCMS
ICPMS
Follow us
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike